Screening of abdominal obesity and diabetes mellitus in women with oncological diseases

Background. The purpose of the study was to assess the presence of excess body weight, abdominal obesity (AO), and type 2 diabetes mellitus (DM) in oncological diseases in women of young and middle age. Materials and methods. 32 outpatient women aged 31 to 59 years with a verified oncological diseas...

Full description

Bibliographic Details
Main Authors: N.O. Pertseva, M.K. Rokutova, V.V. Melnik
Format: Article
Language:English
Published: Publishing House Zaslavsky 2017-11-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/119275
id doaj-36a7b90efc3b41ad8db702bce25f5f27
record_format Article
spelling doaj-36a7b90efc3b41ad8db702bce25f5f272020-11-24T21:54:45ZengPublishing House ZaslavskyMìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272017-11-0113858659010.22141/2224-0721.13.8.2017.119275119275Screening of abdominal obesity and diabetes mellitus in women with oncological diseasesN.O. Pertseva0M.K. Rokutova1V.V. Melnik2State Institution “Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine”, Dnipro, UkraineState Institution “Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine”, Dnipro, UkraineState Institution “Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine”, Dnipro, UkraineBackground. The purpose of the study was to assess the presence of excess body weight, abdominal obesity (AO), and type 2 diabetes mellitus (DM) in oncological diseases in women of young and middle age. Materials and methods. 32 outpatient women aged 31 to 59 years with a verified oncological disease were examined. Standard clinical methods of investigation, statistical processing of results by nonparametric statistics were used. Results. Cervical cancer was verified in 24 (75.0 %) persons, breast adenocarcinoma — in 5 (15.6 %), rectal cancer — in 3 (9.4 %) patients. Elevated body mass index was detected in 24 (75.0 %) women: excess body weight — in 11 (34.4%), AO stage I — in 8 (25.0%), stage II — in 5 persons (15.6 %). Overweight or AO were detected in 30 (93.8 %) patients according to waist-to-height ratio. Type 2 DM was detected only in 2 patients (6.3 %). A heredity in oncopathology was recorded in half of women, of them for AO — in 8 (25.0 %), for type 2 DM — in 5 (15.6 %) patients. A direct correlation was established between heredity in oncological disease and body weight (r = 0.62, p < 0.01), waist circumference (r = 0.61, p < 0.01), body mass index (r = 0.66, p < 0.01), waist-to-height ratio (r = 0.49, p <0.05), waist circumference/hip circumference ratio (r = 0.41, p < 0.01). Conclusions. Overweight and obesity are common among women with cancer, especially, with cervical cancer. Correlation between increased anthropometric indicators and a family history of oncological diseases among women was noted. For comprehensive diagnosis of overweight, in addition to the standard anthropometric indicators, the waist-to-height ratio should be used, as well as additional examinations to detect type 2 DM, insulin resistance, metabolic changes.http://iej.zaslavsky.com.ua/article/view/119275abdominal obesityoncological diseasestype 2 diabetes mellitusinsulin resistancewaist-to-height ratiopeople of young and middle age
collection DOAJ
language English
format Article
sources DOAJ
author N.O. Pertseva
M.K. Rokutova
V.V. Melnik
spellingShingle N.O. Pertseva
M.K. Rokutova
V.V. Melnik
Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
Mìžnarodnij Endokrinologìčnij Žurnal
abdominal obesity
oncological diseases
type 2 diabetes mellitus
insulin resistance
waist-to-height ratio
people of young and middle age
author_facet N.O. Pertseva
M.K. Rokutova
V.V. Melnik
author_sort N.O. Pertseva
title Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
title_short Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
title_full Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
title_fullStr Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
title_full_unstemmed Screening of abdominal obesity and diabetes mellitus in women with oncological diseases
title_sort screening of abdominal obesity and diabetes mellitus in women with oncological diseases
publisher Publishing House Zaslavsky
series Mìžnarodnij Endokrinologìčnij Žurnal
issn 2224-0721
2307-1427
publishDate 2017-11-01
description Background. The purpose of the study was to assess the presence of excess body weight, abdominal obesity (AO), and type 2 diabetes mellitus (DM) in oncological diseases in women of young and middle age. Materials and methods. 32 outpatient women aged 31 to 59 years with a verified oncological disease were examined. Standard clinical methods of investigation, statistical processing of results by nonparametric statistics were used. Results. Cervical cancer was verified in 24 (75.0 %) persons, breast adenocarcinoma — in 5 (15.6 %), rectal cancer — in 3 (9.4 %) patients. Elevated body mass index was detected in 24 (75.0 %) women: excess body weight — in 11 (34.4%), AO stage I — in 8 (25.0%), stage II — in 5 persons (15.6 %). Overweight or AO were detected in 30 (93.8 %) patients according to waist-to-height ratio. Type 2 DM was detected only in 2 patients (6.3 %). A heredity in oncopathology was recorded in half of women, of them for AO — in 8 (25.0 %), for type 2 DM — in 5 (15.6 %) patients. A direct correlation was established between heredity in oncological disease and body weight (r = 0.62, p < 0.01), waist circumference (r = 0.61, p < 0.01), body mass index (r = 0.66, p < 0.01), waist-to-height ratio (r = 0.49, p <0.05), waist circumference/hip circumference ratio (r = 0.41, p < 0.01). Conclusions. Overweight and obesity are common among women with cancer, especially, with cervical cancer. Correlation between increased anthropometric indicators and a family history of oncological diseases among women was noted. For comprehensive diagnosis of overweight, in addition to the standard anthropometric indicators, the waist-to-height ratio should be used, as well as additional examinations to detect type 2 DM, insulin resistance, metabolic changes.
topic abdominal obesity
oncological diseases
type 2 diabetes mellitus
insulin resistance
waist-to-height ratio
people of young and middle age
url http://iej.zaslavsky.com.ua/article/view/119275
work_keys_str_mv AT nopertseva screeningofabdominalobesityanddiabetesmellitusinwomenwithoncologicaldiseases
AT mkrokutova screeningofabdominalobesityanddiabetesmellitusinwomenwithoncologicaldiseases
AT vvmelnik screeningofabdominalobesityanddiabetesmellitusinwomenwithoncologicaldiseases
_version_ 1725866017819721728